UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037206
Receipt number R000042374
Scientific Title Organ preserving strategy "Watch and Wait" for rectal adenocarcinoma acheived clinical complete response treated with chemoradiotherapy
Date of disclosure of the study information 2019/09/01
Last modified on 2020/07/03 15:27:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Organ preserving strategy "Watch and Wait" for rectal adenocarcinoma acheived clinical complete response treated with chemoradiotherapy

Acronym

Watch and Wait trial

Scientific Title

Organ preserving strategy "Watch and Wait" for rectal adenocarcinoma acheived clinical complete response treated with chemoradiotherapy

Scientific Title:Acronym

Watch and Wait trial

Region

Japan


Condition

Condition

low rectal cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To assess organ preserving rate of patient treated with watch and wait strategy

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

organ preserving rate

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

watch and wait strategy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

low rectal adenocarcinoma
clinical complete response by chemoradiothrapy
assessment was conducted 10-12 weeks after chemoradiotherapy. clinical complete response fulfilled all criteria:the absence of residual ulceration, mass, mucosal irregularity at digital examination and endoscopic assessment. no evidence of residual disease at CT and MRI.

Key exclusion criteria

patients who are not to be able to understand the study and sign the informed consent to participate due to any reasons

Target sample size

15


Research contact person

Name of lead principal investigator

1st name Hisahiro
Middle name
Last name Matsubara

Organization

Graduate school of medicine,Chiba university

Division name

Department of Frontier Surgery

Zip code

260-8670

Address

1-8-1 Inohana, Chuo-ku, Chiba,Japan

TEL

043-226-2109

Email

matsuhm@faculty.chiba-u.jp


Public contact

Name of contact person

1st name Shunsuke
Middle name
Last name Imanishi

Organization

Graduate school of medicine, Chiba university

Division name

Department of Frontier

Zip code

260-8670

Address

1-8-1 Inohana, Chuo-ku, Chiba,Japan

TEL

043-226-2109

Homepage URL


Email

shun_imanishi@chiba-u.jp


Sponsor or person

Institute

Chiba University hospital

Institute

Department

Personal name



Funding Source

Organization

No

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Chiba University hospital

Address

1-8-1,Inohana Chuo-ku,Chiba,Japan

Tel

043-222-7171

Email

prc-jm@chiba-u.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2019 Year 08 Month 01 Day

Date of IRB

2019 Year 10 Month 01 Day

Anticipated trial start date

2019 Year 10 Month 01 Day

Last follow-up date

2027 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 06 Month 28 Day

Last modified on

2020 Year 07 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042374


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name